Search
Esmolol Action Pathway (New)
smpdb.ca/view/SMP0126202Drug actionIt can be administered orally, where it passes through hepatic portal circulation, and enters the bloodstream and travels to act on cardiomyocytes. … cAMP, PKA, SRC and nitric oxide synthase signaling.
Enzymes: Sodium/calcium exchanger 1, Voltage-dependent T-type calcium channel subunit alpha-1GOxprenolol B1-Adrenergic Cardiac Muscle Relaxation Action Pathway
smpdb.ca/view/SMP0126219Drug actionIt can be administered orally, where it passes through hepatic portal circulation, and enters the bloodstream and travels to act on cardiomyocytes. … cAMP, PKA, SRC and nitric oxide synthase signaling.
Enzymes: Sodium/calcium exchanger 1, Voltage-dependent T-type calcium channel subunit alpha-1GPenbutolol Action Pathway (New)
smpdb.ca/view/SMP0126220Drug actionIt can be administered orally, where it passes through hepatic portal circulation, and enters the bloodstream and travels to act on cardiomyocytes. … cAMP, PKA, SRC and nitric oxide synthase signaling.
Enzymes: Sodium/calcium exchanger 1, Voltage-dependent T-type calcium channel subunit alpha-1GNorepinephrine Beta-1 Adrenergic Cardiac Action Pathway
smpdb.ca/view/SMP0126438Drug actionThis calcium binds with troponin to activate tropomyosin which leads to contraction of the heart. Myosin, with an ADP and phosphate attached, binds to actin to form a cross bridge. … The voltage-gated calcium channels allow calcium to enter the cell. The calcium activates the ryanodine receptor on the sarcoplasmic reticulum in order to release more calcium into the cytosol.
Enzymes: Sodium/calcium exchanger 1, Voltage-dependent T-type calcium channel subunit alpha-1GTimolol B1-Adrenergic Cardiac Muscle Relaxation Action Pathway
smpdb.ca/view/SMP0126503Drug actionBeta(1)-receptor blockade by timolol leads to a decrease in both heart rate and cardiac output during rest and exercise, and a decrease in both systolic and diastolic blood pressure. … When administered in the tablet form, it reduces blood pressure, heart rate, and cardiac output, and decreases sympathetic activity.
Enzymes: Sodium/calcium exchanger 1, Voltage-dependent T-type calcium channel subunit alpha-1GPindolol B1-Adrenergic Cardiac Muscle Relaxation Action Pathway
smpdb.ca/view/SMP0126651Drug actionIncreased intracellular calcium increase inotropy in the heart through calcium-induced exchange facilitated by the sarcoplasmic reticulum. … Beta-1 receptors are G-protein-coupled receptors (specifically Gs alpha subunit) whose action is exerted through the cyclic AMP (cAMP) and cAMP-dependent protein kinase action with resultant calcium ion
Enzymes: Sodium/calcium exchanger 1, Voltage-dependent T-type calcium channel subunit alpha-1GDopamine Action Pathway
smpdb.ca/view/SMP0125137Drug actionProtein kinase activates calcium channels in the membrane, causing the channels to open and allow Ca2+ into the cell. … The high concentration of Ca2+ binds to troponin to cause cardiac muscle contractions and therefore, an increased heart rate.
Enzymes: Sodium/calcium exchanger 1, Voltage-dependent P/Q-type calcium channel subunit alpha-1ADopamine Action Pathway
smpdb.ca/view/SMP0127069PhysiologicalProtein kinase activates calcium channels in the membrane, causing the channels to open and allow Ca2+ into the cell. … The high concentration of Ca2+ binds to troponin to cause cardiac muscle contractions and therefore, an increased heart rate.
Enzymes: Sodium/calcium exchanger 1, Voltage-dependent P/Q-type calcium channel subunit alpha-1ABopindolol Action Pathway (New)
smpdb.ca/view/SMP0126187Drug actioncAMP, PKA, SRC and nitric oxide synthase signaling. … It can be administered orally, where it passes through hepatic portal circulation, and enters the bloodstream and travels to act on cardiomyocytes.
Enzymes: Sodium/calcium exchanger 1, Sarcoplasmic/endoplasmic reticulum calcium ATPase 2Felodipine Metabolism Pathway
smpdb.ca/view/SMP0000619Drug metabolismCalcium ions entering the cell through these channels bind to calmodulin. Calcium-bound calmodulin then binds to and activates myosin light chain kinase (MLCK). … Felodipine decreases arterial smooth muscle contractility and subsequent vasoconstriction by inhibiting the influx of calcium ions through L-type calcium channels.
Drugs: FelodipineEnzymes: Voltage-dependent L-type calcium channel subunit beta-1, Voltage-dependent L-type calcium channel subunit alpha-1C